Response to Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Letter]

Detalles Bibliográficos
Autores principales: Panjaitan, Novaria Sari Dewi, Lestari, Christina Safira Whinie, Maha, Masri Sembiring
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760064/
https://www.ncbi.nlm.nih.gov/pubmed/36540346
http://dx.doi.org/10.2147/DMSO.S399410
_version_ 1784852375837605888
author Panjaitan, Novaria Sari Dewi
Lestari, Christina Safira Whinie
Maha, Masri Sembiring
author_facet Panjaitan, Novaria Sari Dewi
Lestari, Christina Safira Whinie
Maha, Masri Sembiring
author_sort Panjaitan, Novaria Sari Dewi
collection PubMed
description
format Online
Article
Text
id pubmed-9760064
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-97600642022-12-19 Response to Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Letter] Panjaitan, Novaria Sari Dewi Lestari, Christina Safira Whinie Maha, Masri Sembiring Diabetes Metab Syndr Obes Letter Dove 2022-12-14 /pmc/articles/PMC9760064/ /pubmed/36540346 http://dx.doi.org/10.2147/DMSO.S399410 Text en © 2022 Panjaitan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Letter
Panjaitan, Novaria Sari Dewi
Lestari, Christina Safira Whinie
Maha, Masri Sembiring
Response to Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Letter]
title Response to Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Letter]
title_full Response to Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Letter]
title_fullStr Response to Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Letter]
title_full_unstemmed Response to Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Letter]
title_short Response to Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Letter]
title_sort response to article “are there differences in gut microbiome in patients with type 2 diabetes treated by metformin or metformin and insulin?” [letter]
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760064/
https://www.ncbi.nlm.nih.gov/pubmed/36540346
http://dx.doi.org/10.2147/DMSO.S399410
work_keys_str_mv AT panjaitannovariasaridewi responsetoarticlearetheredifferencesingutmicrobiomeinpatientswithtype2diabetestreatedbymetforminormetforminandinsulinletter
AT lestarichristinasafirawhinie responsetoarticlearetheredifferencesingutmicrobiomeinpatientswithtype2diabetestreatedbymetforminormetforminandinsulinletter
AT mahamasrisembiring responsetoarticlearetheredifferencesingutmicrobiomeinpatientswithtype2diabetestreatedbymetforminormetforminandinsulinletter

Ejemplares similares